- RBC analysts say spinoff could be path for fastest exit
- Buybacks could resume before official separation, analysts say
MetLife Inc. may favor a spinoff of its Brighthouse Financial U.S. business rather than pursue an initial public offering of the unit, RBC Capital Markets analysts led by Eric Berg said after chatting with the company’s chief financial officer.
“A ‘spin’ would get the majority of the highly capital-markets-sensitive, and therefore volatile, retail business off of Met’s books a lot sooner than would an IPO,” the analysts said Wednesday in a note. “If speed is, in fact, what is first and foremost on the minds of Met’s leadership, then we would say a ‘spin’ of Brighthouse is Met’s most likely choice.”
Chief Executive Officer Steve Kandarian announced a plan in January to separate the business that sells life insurance and variable annuities to individuals, an operation that has been pressured by low bond yields. He initially said possibilities included a sale, spinoff or IPO, but told analysts Aug. 4 that he expects to file documents tied to one of the latter two options shortly after a board meeting late next month.
Tax considerations would likely limit New York-based MetLife to selling only 20 percent of Brighthouse in an IPO, and the insurer would have to wait six months to exit the rest, Berg wrote. He said his view of MetLife’s approach was drawn from “inferences” after traveling with CFO John Hele rather than direct remarks from the executive. For instance, Hele spoke about companies in other industries that separated businesses by spinning them off to shareholders, according to the analyst.
“Met’s CFO wouldn’t be studying these other spinoffs and highlighting them unless he were at least giving very serious consideration” to such an approach, Berg wrote.
The business designated for separation would have more than $200 billion in assets, the company said in January. MetLife plans to retain U.S. operations that provide workplace benefits along with international businesses in regions such as Asia and Latin America.
Berg has an outperform rating on MetLife stock and said he now believes that the company could resume share buybacks as soon as October. The insurer is unable to repurchase shares until deciding which separation path it will pursue, Kandarian said in February. Berg had previously believed that buybacks would be on hold until early 2017, when he expects the separation will occur.
Randy Clerihue, a spokesman for MetLife, declined to comment.
The insurer advanced 29 cents to $40.88 at 9:36 a.m. in New York, narrowing its decline for the year to 15 percent. The stock dropped 11 percent in 2015.